通过ADMET-AI可进行药物诱导心脏毒性预测
Souhrid Mukherjee1,2, Kyle Swanson3,4,2, Parker Walther2
1Stanford Cardiovascular Institute (S.M., R.V.S., P.D.P., J.C.W.), Stanford University, CA.
No abstract available in PubMed .
更多相关视频
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: β-Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Analysis of Population Pharmacokinetic Data
